The impact of eszopiclone on sleep and cognition in patients with schizophrenia and insomnia: A double-blind, randomized, placebo-controlled trial

Podobne zapisy

• Investigating the safety and efficacy of naltrexone for anti-psychotic induced weight gain in severe mental illness: study protocol of a double-blind, randomized, placebo-controlled trial
  od: Tek, Cenk, i wsp.
  Wydane: (2013)
• Insomnia is frequent in schizophrenia and associated with night eating and obesity
  od: Palmese, Laura B., i wsp.
  Wydane: (2011)
• High Rates of Obstructive Sleep Apnea Symptoms Among Patients With Schizophrenia
  od: Annamalai, Aniyizhai, i wsp.
  Wydane: (2014)
• A Randomized, Double-Blind, Placebo-Controlled Trial of Eszopiclone for the Treatment of Insomnia in Patients with Chronic Low Back Pain
  od: Goforth, Harold W., i wsp.
  Wydane: (2014)
• Obese schizophrenia spectrum patients have significantly higher 10-year general cardiovascular risk and vascular ages than obese individuals without severe mental illness
  od: Ratliff, Joseph C., i wsp.
  Wydane: (2012)